| |
| |
|
| Insider
Information: |
Conterno Enrique A |
| Relationship: |
Chief Executive Office... |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
507,684 |
|
|
Indirect Shares
|
32,959 |
|
|
| Direct
Value |
$113,428,565 |
|
|
|
Indirect Value
|
$4,415,678 |
|
|
| Total
Shares |
540,643 |
|
|
| Total
Value |
$117,844,243 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
7
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
-7.0
|
| Percentage
Gain/Loss : |
 -5.7%
|
-569.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
SVP&Pres, LillyDiab & ... |
2019-02-15 |
132,962 |
2019-02-15 |
5,159 |
Premium* |
|
|
Fibrogen Inc |
FGEN |
Chief Executive Office... |
2023-07-07 |
374,722 |
2023-07-07 |
27,800 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Sr. VP, Diabetes Business Unit |
• – – |
2009-11-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,919 |
|
- |
|
| FGEN |
Fibrogen Inc |
Chief Executive Officer |
• • – |
2020-06-10 |
4 |
B |
$36.29 |
$290,282 |
I/I |
8,000 |
8,000 |
2.66 |
% |
|
| LLY |
Eli Lilly & Co |
Sr. VP, Diabetes Business Unit |
• – – |
2009-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,392 |
|
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2010-10-18 |
4 |
D |
$37.76 |
$93,985 |
D/D |
(2,489) |
25,238 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2012-08-01 |
4 |
AS |
$44.16 |
$220,800 |
D/D |
(5,000) |
27,012 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Diabetes BU |
• – – |
2010-01-26 |
4 |
A |
$36.16 |
$662,994 |
D/D |
18,335 |
27,727 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Chief Executive Officer |
• • – |
2020-06-11 |
4 |
B |
$35.28 |
$698,599 |
I/I |
19,800 |
27,800 |
2.66 |
% |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2012-07-02 |
4 |
AS |
$43.00 |
$215,000 |
D/D |
(5,000) |
32,012 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2012-06-01 |
4 |
AS |
$40.60 |
$203,000 |
D/D |
(5,000) |
37,012 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2012-05-01 |
4 |
AS |
$41.32 |
$206,600 |
D/D |
(5,000) |
42,012 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2011-01-25 |
4 |
A |
$34.73 |
$682,688 |
D/D |
19,657 |
44,895 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2012-04-02 |
4 |
AS |
$40.30 |
$201,500 |
D/D |
(5,000) |
47,012 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2012-01-26 |
4 |
A |
$39.44 |
$280,694 |
D/D |
7,117 |
52,012 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Chief Executive Officer |
• • – |
2021-01-06 |
4 |
D |
$38.31 |
$207,295 |
D/D |
(5,411) |
55,273 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-08-15 |
4 |
AS |
$53.79 |
$268,950 |
D/D |
(5,000) |
57,177 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Chief Executive Officer |
• • – |
2020-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-01-25 |
4 |
A |
$53.21 |
$1,756,835 |
D/D |
33,017 |
60,029 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-07-15 |
4 |
AS |
$51.43 |
$257,150 |
D/D |
(5,000) |
62,177 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-06-17 |
4 |
AS |
$52.45 |
$262,250 |
D/D |
(5,000) |
67,177 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-04-15 |
4 |
AS |
$57.10 |
$285,500 |
D/D |
(5,000) |
71,875 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-05-15 |
4 |
AS |
$56.15 |
$280,750 |
D/D |
(5,000) |
72,177 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2014-11-03 |
4 |
AS |
$66.03 |
$330,150 |
D/D |
(5,000) |
72,736 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2014-12-10 |
4 |
D |
$72.21 |
$436,582 |
D/D |
(6,046) |
73,791 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2014-12-10 |
4/A |
D |
$72.21 |
$395,278 |
D/D |
(5,474) |
74,363 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2013-02-01 |
4 |
D |
$53.69 |
$801,162 |
D/D |
(14,922) |
76,875 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
